TITLE

Phosphodiesterase inhibitors: Lily the Pink's medicinal compound for asthma?

AUTHOR(S)
Dent, G; Giembycz, M A
PUB. DATE
June 1996
SOURCE
Thorax;Jun1996, Vol. 51 Issue 6, p647
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66106710

 

Related Articles

  • Phosphodiesterase 5 inhibitors: current status and potential applications. Rotella, David P. // Nature Reviews Drug Discovery;Sep2002, Vol. 1 Issue 9, p674 

    Phosphodiesterase enzymes convert cyclic GMP and cyclic AMP to the corresponding nucleotide monophosphates. Phosphodiesterase 5 (PDE5) inhibition is now a widely accepted and efficacious therapeutic option for the treatment of erectile dysfunction in men, as a result of extensive clinical...

  • Pink. Cruze, Karen // Booklist;1/1/2011 - 1/15/2011, Vol. 107 Issue 9/10, p97 

    Reviews the book "Pink," by Lili Wilkinson.

  • Asthma drug also reduces COPD exacerbations.  // Pulse;5/18/2011, Vol. 71 Issue 18, p11 

    The article reports on the role of asthma drugs, such as an oral phosphodiesterase-4 (PDE4) inhibitors roflumilast or cilomast, in improving lung function and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD).

  • Atlanta Highlights Positive Roflumilast Trials.  // Chemical Market Reporter;10/6/2003, Vol. 264 Issue 11, p7 

    Reports on the positive results from the clinical tests of phosphodiesterase-4 inhibitor by Altana AG in Germany. Application for European regulatory approval; Treatment options for chronic obstructive pulmonary disease (COPD) and asthma; Competitiveness in the respiratory COPD sector.

  • Pink. Campbell, Jane // Reading Time;Aug2009, Vol. 53 Issue 3, p39 

    The article reviews the book "Pink," by Lili Wilkinson.

  • Pink. Bennett, Sandra // School Librarian;Spring2011, Vol. 59 Issue 1, p58 

    The article reviews the book "Pink," by Lili Wilkinson.

  • Pink.  // Bookmarks (15460657);Jul/Aug2011, Issue 53, p48 

    The article reviews the book "Pink," by Lili Wilkinson.

  • PINK.  // Kirkus Reviews;1/1/2011, Vol. 79 Issue 1, p66 

    The article reviews the book "Pink," by Lili Wilkinson.

  • Editorial [Guest Editor: Strategies for the Improvement of Asthma Therapy (Executive Editor: Andreas Pahl)]. Pahl, Andreas // Current Pharmaceutical Design;Sep2006, Vol. 12 Issue 25, p3173 

    Asthma bronchiale, affecting 155 millions people worldwide, has emerged as a major public health problem worldwide over the past 20 years. Although data indicate that current asthma therapies led to limited decreases in death rates, it continues to be a significant health care problem. As we...

  • Recent Advances in PDE4 Inhibitors as Immunoregulators and Anti- Inflammatory Drugs. Burnouf, Catherine; Pruniaux, Marie-Pierre // Current Pharmaceutical Design;Jun2002, Vol. 8 Issue 14, p1255 

    The phosphodiesterases (PDEs) are responsible for the hydrolysis of intracellular cyclic adenosine and guanosine monophosphate (cAMP and cGMP, respectively). They are classified into 11 major families (PDE1-11) and the type 4 phosphodiesterase (PDE4) is a cAMP-specific enzyme localized in airway...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics